Exhibit 107
CALCULATION OF THE REGISTRATION FEE
| | | | | | | | |
Title of Each Class of Securities to be Registered | | Amount to be
Registered | | Proposed
Maximum
Offering Price
per Security | | Proposed
Maximum
Aggregate
Offering Price | | Amount of
Registration
Fee |
€800,000,000 7.375% Sustainability-Linked Senior Notes due 2029 | | €800,000,000 | | 100% | | €800,000,000 | | $94,331.20(1) |
€500,000,000 7.875% Sustainability-Linked Senior Notes due 2031 | | €500,000,000 | | 100% | | €500,000,000 | | $58,957.00(1) |
$600,000,000 7.875% Sustainability-Linked Senior Notes due 2029 | | $600,000,000 | | 100% | | $600,000,000 | | $66,120.00(2) |
$500,000,000 8.125% Sustainability-Linked Senior Notes due 2031 | | $500,000,000 | | 100% | | $500,000,000 | | $55,100.00(2) |
Total | | $2,491,000,000(4) | | N/A | | $2,491,000,000(4) | | $274,508.20(3) |
(1) Calculated in accordance with Rule 457(r) under the Securities Act of 1933, as amended (the “Securities Act”), based upon the euro/dollar rate of exchange of €1/$1.07 as of March 1, 2023, as reported by Bloomberg.
(2) Calculated in accordance with Rule 457(r) under the Securities Act.
(3) We have previously paid $622,500 in registration fees in connection with the offering of our securities having an aggregate offering price of up to $5,000,000,000 pursuant to the registration statement filed on Form S-3 (File No. 333-222767) by Teva Pharmaceutical Industries Limited and certain of its finance subsidiaries on January 29, 2018. Pursuant to Rule 457(p) under the Securities Act, $464,487.55 of the previously paid registration fee was carried forward to the Registration Statement on Form S-3ASR (No. 333-260519) filed on October 27, 2021. As of the date hereof, $158,012.45 was unused. Pursuant to Rule 457(p) under the Securities Act, we carry forward these unused filing fees to partially offset the registration fee of $274,508.20 due in connection with this prospectus supplement. The balance of the registration fee is $116,495.75.
(4) Calculated based upon the euro/dollar rate of exchange of €1/$1.07 as of March 1, 2023, as reported by Bloomberg.
